Shopping Cart
Remove All
Your shopping cart is currently empty
LY3526318 is an orally active, selective TRPA1 antagonist with an IC50 of 5-6 μM. It blocks the TRPA1 channel, inhibiting pain signal transduction mediated by this channel and demonstrating analgesic activity. LY3526318 is primarily utilized in research related to chronic pain, such as diabetic peripheral neuropathic pain, chronic lower back pain, and osteoarthritis-induced pain.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | LY3526318 is an orally active, selective TRPA1 antagonist with an IC50 of 5-6 μM. It blocks the TRPA1 channel, inhibiting pain signal transduction mediated by this channel and demonstrating analgesic activity. LY3526318 is primarily utilized in research related to chronic pain, such as diabetic peripheral neuropathic pain, chronic lower back pain, and osteoarthritis-induced pain. |
| In vitro | LY3526318 effectively inhibits the inward current activation of transient TRPA1 by Allyl Isothiocyanate. The IC50 values for TRPA1 ion channels are 13.5 nM for humans, 55.7 nM for rats, 7.6 nM for dogs, and 8.2 nM for cynomolgus monkeys. |
| Molecular Weight | 556.46 |
| Formula | C23H19F3N10O4 |
| Cas No. | 1889218-34-1 |
| Smiles | [C@@H](C(NC=1N=C(C=CC1)C=2C=NC(C(F)(F)F)=NC2)=O)(C)N3C4=C(N(C)C(=O)N(CC5=NC(C)=NO5)C4=O)N=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.